192 related articles for article (PubMed ID: 36788224)
1. Multilevel proteomic analyses reveal molecular diversity between diffuse-type and intestinal-type gastric cancer.
Shi W; Wang Y; Xu C; Li Y; Ge S; Bai B; Zhang K; Wang Y; Zheng N; Wang J; Wang S; Ji G; Li J; Nie Y; Liang W; Wu X; Cui J; Wang Y; Chen L; Zhao Q; Shen L; He F; Qin J; Ding C
Nat Commun; 2023 Feb; 14(1):835. PubMed ID: 36788224
[TBL] [Abstract][Full Text] [Related]
2. Histological and mutational profile of diffuse gastric cancer: current knowledge and future challenges.
Garcia-Pelaez J; Barbosa-Matos R; Gullo I; Carneiro F; Oliveira C
Mol Oncol; 2021 Nov; 15(11):2841-2867. PubMed ID: 33724653
[TBL] [Abstract][Full Text] [Related]
3. Association of Helicobacter pylori and diffuse type gastric cancer.
Handa Y; Saitoh T; Kawaguchi M; Misaka R; Ohno H; Tsai CR; Tani Y; Tsurui M; Yoshida H; Morita S; Midorikawa S; Sanji T
J Gastroenterol; 1996 Nov; 31 Suppl 9():29-32. PubMed ID: 8959514
[TBL] [Abstract][Full Text] [Related]
4. Identification of differential gene expression between intestinal and diffuse gastric cancer using cDNA microarray.
Wu CM; Lee YS; Wang TH; Lee LY; Kong WH; Chen ES; Wei ML; Liang Y; Hwang TL
Oncol Rep; 2006 Jan; 15(1):57-64. PubMed ID: 16328034
[TBL] [Abstract][Full Text] [Related]
5. Association between the CDH1-472delA and -160C>A polymorphisms and diffuse and intestinal gastric cancer in a Mexican population.
Bustos-Carpinteyro AR; Delgado-Figueroa N; Santiago-Luna E; Magaña-Torres MT; Sánchez-López JY
Genet Mol Res; 2016 Sep; 15(3):. PubMed ID: 27706737
[TBL] [Abstract][Full Text] [Related]
6. PGP9.5 methylation in diffuse-type gastric cancer.
Yamashita K; Park HL; Kim MS; Osada M; Tokumaru Y; Inoue H; Mori M; Sidransky D
Cancer Res; 2006 Apr; 66(7):3921-7. PubMed ID: 16585221
[TBL] [Abstract][Full Text] [Related]
7. Identification of cancer stem cell-related biomarkers in intestinal-type and diffuse-type gastric cancer by stemness index and weighted correlation network analysis.
Guo R; Chu A; Gong Y
J Transl Med; 2020 Nov; 18(1):418. PubMed ID: 33160391
[TBL] [Abstract][Full Text] [Related]
8. Identification of genomic aberrations associated with lymph node metastasis in diffuse-type gastric cancer.
Choi JH; Kim YB; Ahn JM; Kim MJ; Bae WJ; Han SU; Woo HG; Lee D
Exp Mol Med; 2018 Apr; 50(4):1-11. PubMed ID: 29622765
[TBL] [Abstract][Full Text] [Related]
9. A proteomic landscape of diffuse-type gastric cancer.
Ge S; Xia X; Ding C; Zhen B; Zhou Q; Feng J; Yuan J; Chen R; Li Y; Ge Z; Ji J; Zhang L; Wang J; Li Z; Lai Y; Hu Y; Li Y; Li Y; Gao J; Chen L; Xu J; Zhang C; Jung SY; Choi JM; Jain A; Liu M; Song L; Liu W; Guo G; Gong T; Huang Y; Qiu Y; Huang W; Shi T; Zhu W; Wang Y; He F; Shen L; Qin J
Nat Commun; 2018 Mar; 9(1):1012. PubMed ID: 29520031
[TBL] [Abstract][Full Text] [Related]
10. In vivo CRISPR-Cas9 knockout screening using quantitative PCR identifies thymosin beta-4 X-linked that promotes diffuse-type gastric cancer metastasis.
An HW; Kim SY; Kwon JW; Seok SH; Woo SH; Kim DY; Park JW
Mol Carcinog; 2021 Sep; 60(9):597-606. PubMed ID: 34081824
[TBL] [Abstract][Full Text] [Related]
11. [Risk factors associated to diffuse gastric cancer and intestinal histological patterns in an adult population from Western Mexico].
Delgado-Figueroa N; Casas-Junco P; Torres-Jasso JH; Bustos-Carpinteyro AR; Santiago-Luna E; Marín-Contreras ME; Sánchez-López JY
Gac Med Mex; 2017; 153(2):173-178. PubMed ID: 28474703
[TBL] [Abstract][Full Text] [Related]
12. Role of Serum Pepsinogen II and
Baek SM; Kim N; Kwon YJ; Lee HS; Kim HY; Lee J; Yoon H; Shin CM; Park YS; Lee DH
Gut Liver; 2020 Jul; 14(4):439-449. PubMed ID: 31533397
[TBL] [Abstract][Full Text] [Related]
13. Different clinical significance of FGFR1-4 expression between diffuse-type and intestinal-type gastric cancer.
Inokuchi M; Murase H; Otsuki S; Kawano T; Kojima K
World J Surg Oncol; 2017 Jan; 15(1):2. PubMed ID: 28056982
[TBL] [Abstract][Full Text] [Related]
14. Copy number alterations and epithelial‑mesenchymal transition genes in diffuse and intestinal gastric cancers in Mexican patients.
Larios-Serrato V; Martínez-Ezquerro JD; Valdez-Salazar HA; Torres J; Camorlinga-Ponce M; Piña-Sánchez P; Ruiz-Tachiquín ME
Mol Med Rep; 2022 May; 25(5):. PubMed ID: 35362543
[TBL] [Abstract][Full Text] [Related]
15. Multi-omics analysis identifies pathways and genes involved in diffuse-type gastric carcinogenesis induced by E-cadherin, p53, and Smad4 loss in mice.
Park JW; Kim MS; Voon DC; Kim SJ; Bae J; Mun DG; Ko SI; Kim HK; Lee SW; Kim DY
Mol Carcinog; 2018 Jul; 57(7):947-954. PubMed ID: 29528141
[TBL] [Abstract][Full Text] [Related]
16. The protein-protein interaction network of intestinal gastric cancer patients reveals hub proteins with potential prognostic value.
Santos EC; Binato R; Fernandes PV; Ferreira MA; Abdelhay E
Cancer Biomark; 2022; 33(1):83-96. PubMed ID: 34366321
[TBL] [Abstract][Full Text] [Related]
17. Alterations in mucin type: an indicator for suspicion of malignant gastric transformation.
Cheah PL; Ramachandran K
Malays J Pathol; 1994 Jun; 16(1):39-42. PubMed ID: 16329574
[TBL] [Abstract][Full Text] [Related]
18. Histological variety of gastric carcinoma and Helicobacter pylori cagA and vacA polymorphism.
Figura N; Valassina M; Moretti E; Vindigni C; Collodel G; Iacoponi F; Giordano N; Roviello F; Marrelli D
Eur J Gastroenterol Hepatol; 2015 Sep; 27(9):1017-21. PubMed ID: 26067222
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of claudin-4 between intestinal and diffuse-type gastric cancer.
Kuo WL; Lee LY; Wu CM; Wang CC; Yu JS; Liang Y; Lo CH; Huang KH; Hwang TL
Oncol Rep; 2006 Oct; 16(4):729-34. PubMed ID: 16969486
[TBL] [Abstract][Full Text] [Related]
20. Profiling Kinase Activities for Precision Oncology in Diffuse Gastric Cancer.
Singh S; Parthasarathi KTS; Bhat MY; Gopal C; Sharma J; Pandey A
OMICS; 2024 Feb; 28(2):76-89. PubMed ID: 38271566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
